Briefing Calendar IPOs Opportunities Companies Compare Analytics Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar with AI-powered predictions. Track FDA decisions, PDUFA dates, clinical trial results, and Phase 3 readouts. Real-time alerts for biotech investors.

Quick Links

This Week's Catalysts
Full Calendar
Catalyst Types
Search Companies
Biotech Glossary
Embed Widget

Legal

About
ML Track Record
Privacy
Terms
Cookies

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

⚠️ Important Legal Disclaimer

Not Financial Advice: CatalystAlert is an informational platform only. We are NOT a registered investment advisor, broker, or dealer. The information provided on this website does not constitute investment advice, financial advice, trading advice, or any other sort of advice, and you should not treat any of the website's content as such.

No Guarantees: All predictions, probability scores, and analyses are based on historical data and machine learning models. Past performance does NOT guarantee future results. Biotech investing is extremely high-risk and you may lose your entire investment.

Data Accuracy: While we strive for accuracy, data may be incomplete, delayed, or contain errors. We aggregate data from third-party sources (FDA, SEC, ClinicalTrials.gov) and are not responsible for their accuracy. Always verify information with official sources before making any decisions.

Your Responsibility: You are solely responsible for your investment decisions. Consult a qualified financial advisor before investing. CatalystAlert and its operators accept no liability for any losses incurred from using this platform.

© 2026 CatalystAlert. All rights reserved.

Data may be delayed or incomplete. Use at your own risk.

Atomoxetine - Phase 2 | PFE Pipeline | CatalystAlert

Atomoxetine

Phase 2

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Attention Deficit Disorder With Hyperactivity

Clinical Trial

Last updated: 1/1/2026

Developer

PFE

PFIZER

Healthcare•North America•NASDAQ

Related Pipeline

Amoxicillin/clavulinic acidPhase 3

Bronchitis, Chronic

DVS-233 SR (desvenlafaxine sustained release )Phase 3

Major Depressive Disorder

Insulin LisproPhase 3

Diabetes Mellitus

bazedoxifene 20 mg/ conjugated estrogens 0.45 mgPhase 3

Menopause

desvenlafaxine succinate (DVS) SRPhase 3

Vasomotor Symptoms

View full pipeline